Among 1,087 chronic pain patients using cannabis, those who combined inhalation and non-inhalation routes reported greater health improvements and more medication substitutions than those using either route alone.
Chronic pain patients using or considering cannabis, clinicians guiding cannabis use, and researchers designing clinical trials.
45% of pain patients use both inhaled and oral cannabis
What the researchers found
Of participants, 45% used both inhalation and non-inhalation routes, 36.2% used inhalation only, and 18.8% used non-inhalation only. The combined group reported significantly greater health improvements and more medication class substitutions than either single-route group. THC-rich products were typically used at night while CBD-rich products were used during the day. All groups reported similar pain reduction.
Why it matters
This is one of the largest studies to characterize how chronic pain patients actually use cannabis in practice, revealing sophisticated self-directed routines involving multiple products, routes, and timing strategies.
The numbers in context
1,087 participants; 45% used combined routes, 36.2% inhalation only, 18.8% non-inhalation only. Combined route users had 0.62 more medication substitutions than non-inhalation users and 0.45 more than inhalation users.
How the study worked
Mixed methods analysis of 1,087 cross-sectional survey responses from adults with chronic pain using cannabis in the US and Canada. Qualitative analysis of open-ended responses about use routines, followed by quantitative comparison of subgroups based on administration routes.
What this study cannot tell us
Cross-sectional self-report data. No verification of diagnoses, products, or outcomes. Selection bias toward cannabis-positive respondents. No control group. Medication substitution self-reported, not verified.
How to read the evidence
Large survey capturing naturalistic use patterns, but self-report and cross-sectional design limit causal claims.
When this study was published
Published in 2022.
The bigger picture
The finding that patients naturally develop multi-route, time-of-day-specific cannabis regimens suggests clinical trials using a single product may not capture how cannabis is most effectively used for pain management.
Questions still open
- Would prescribing multi-route regimens outperform single-route in clinical trials? Is the nighttime THC / daytime CBD pattern optimal? Do patients using multiple routes have higher tolerance or dependence risk?
Common questions
How do chronic pain patients typically use cannabis?
Did using multiple cannabis routes produce better outcomes?
Read the original research
A mixed methods analysis of cannabis use routines for chronic pain management.
Journal of cannabis research, 4(1), 7
Citation
Boehnke, Kevin F; Yakas, Laura; Scott, J Ryan; DeJonckheere, Melissa; Litinas, Evangelos; Sisley, Suzanne; Clauw, Daniel J; Williams, David A; McAfee, Jenna. (2022). A mixed methods analysis of cannabis use routines for chronic pain management.. Journal of cannabis research, 4(1), 7. https://doi.org/10.1186/s42238-021-00116-7
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk